391 related articles for article (PubMed ID: 7019435)
1. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
Spellacy WN; Birk SA; Buggie J; Buhi WC
J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
[TBL] [Abstract][Full Text] [Related]
2. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
Spellacy WN; Ellingson AB; Tsibris JC
J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
[TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
4. Long-term profile of a new progestin.
Lippman J
Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
6. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Kamau RK; Maina FW; Kigondu C; Mati JK
East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral contraceptives on carbohydrate metabolism.
Wynn V; Godsland I
J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
[TBL] [Abstract][Full Text] [Related]
8. Low dosage oral contraception in women with previous gestational diabetes.
Skouby SO; Mølsted-Pedersen L; Kühl C
Obstet Gynecol; 1982 Mar; 59(3):325-8. PubMed ID: 6804901
[TBL] [Abstract][Full Text] [Related]
9. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.
Spellacy WN; Ellingson AB; Tsibris JC
Fertil Steril; 1989 Jan; 51(1):71-4. PubMed ID: 2642814
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.
Spellacy WN; Tsibris AM; Tsibris JC; George S; Chez RA; O'Brien WF
Contraception; 1994 Feb; 49(2):125-30. PubMed ID: 8143452
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
Kamal I; Zaki K; Rashad S
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079
[TBL] [Abstract][Full Text] [Related]
14. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
15. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
Spellacy WN
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
18. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
19. The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
Nikschick S; Göretzlehner G; Männchen E; Brachmann K
Exp Clin Endocrinol; 1985 Jun; 85(3):257-62. PubMed ID: 3899684
[TBL] [Abstract][Full Text] [Related]
20. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
Norris LA; Bonnar J
Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]